Comments

Vor Biopharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Vor Biopharma (VOR) operate in?

Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VORNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.8844

0.000.00%

Pre-Market: 4:00 PM EDT

Q4 2024 Earnings were released on Thu Mar 20th, after the market close

Vor Biopharma (VOR) Forecast

News Earnings Vor Biopharma (VOR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Vor Biopharma Stock Price, Quotes and Forecasts | NASDAQ:VOR | Benzinga

Explore Vor Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VOR.

Open	-
Close	-
Volume / Avg.	15.00 / 654.75K
Day Range	- - -
52 Wk Range	0.63 - 2.43
Market Cap	$110.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.55%
Days to Cover	4.41

Recent News

What's Going On With Vor Biopharma Shares Friday?

Vor shares are higher lower on Friday after the company announced it has entered into a securities purchase agreement for a private investment in public equity financing.

Dylan Berman

Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?

Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	15.00 / 654.75K
Day Range	- - -
52 Wk Range	0.63 - 2.43
Market Cap	$110.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.55%
Days to Cover	4.41

About Vor Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vor Biopharma (VOR) stock?

You can purchase shares of Vor Biopharma (NASDAQ:VOR) through any online brokerage.

View our list of the best stock brokerages

Who are Vor Biopharma (VOR) competitors?

Other companies in Vor Biopharma’s space includes: Macrogenics (NASDAQ:MGNX), Renovaro (NASDAQ:RENB), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).

What is the forecast, or price target, for Vor Biopharma (VOR) stock?

Vor Biopharma has a consensus price target of $10.40.

What is the current price for Vor Biopharma (VOR)?

The stock price for Vor Biopharma (NASDAQ: VOR) is $0.8844 last updated March 24, 2025 at 4:00 PM EDT.

Does Vor Biopharma (VOR) pay a dividend?

There are no upcoming dividends for Vor Biopharma.

When is Vor Biopharma (NASDAQ:VOR) reporting earnings?

Vor Biopharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Vor Biopharma (VOR) going to split?

There is no upcoming split for Vor Biopharma.

What sector and industry does Vor Biopharma (VOR) operate in?

Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.